Literature DB >> 25052821

Controlled reoxygenation during cardiopulmonary bypass decreases markers of organ damage, inflammation, and oxidative stress in single-ventricle patients undergoing pediatric heart surgery.

Massimo Caputo1, Amir Mokhtari2, Antonio Miceli2, Mohamed T Ghorbel2, Gianni D Angelini2, Andrew J Parry3, Saadeh M Suleiman2.   

Abstract

OBJECTIVE: Single-ventricle patients undergoing pediatric heart surgery are a high-risk group owing to reoxygenation injury during cardiopulmonary bypass (CPB). The present study investigated the effects of controlled reoxygenation CPB on biomarkers of organ damage, inflammation, stress, and long-term functional outcomes in cyanotic patients with either a single or double ventricle during open heart surgery.
METHODS: Cyanotic patients with either a single (n = 32) or double (n = 47) ventricle undergoing surgical correction were randomized to receive CPB using either standard oxygen levels or controlled reoxygenation. The markers of cardiac injury, inflammation, stress, and cerebral and hepatic injury were measured preoperatively, at 10 and 30 minutes after starting CPB, and at 10 minutes and 4 and 24 hours after CPB. The data were analyzed using a mixed regression model.
RESULTS: No difference was found in the pre- or intraoperative characteristics between the standard and controlled reoxygenation CPB groups for single- or double-ventricle patients. In the single-ventricle patients, controlled reoxygenation CPB significantly (P < .05) decreased the markers of organ damage, inflammation, stress, and oxidative stress. In contrast, the markers of inflammation and cardiac injury were not altered by controlled reoxygenation CPB in the double-ventricle patients.
CONCLUSIONS: Controlled reoxygenation CPB decreased the markers of organ damage, stress, inflammation, and oxidative stress in single-ventricle patients undergoing cardiac surgery.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25052821     DOI: 10.1016/j.jtcvs.2014.06.001

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  20 in total

1.  Cardioprotection during Adult and Pediatric Open Heart Surgery.

Authors:  M-Saadeh Suleiman; Malcolm Underwood; Hajime Imura; Massimo Caputo
Journal:  Biomed Res Int       Date:  2015-06-23       Impact factor: 3.411

Review 2.  Accelerated Cardiac Aging in Patients With Congenital Heart Disease.

Authors:  Dominga Iacobazzi; Valeria Vincenza Alvino; Massimo Caputo; Paolo Madeddu
Journal:  Front Cardiovasc Med       Date:  2022-05-26

3.  Does supply meet demand? A comparison of perfusion strategies on cerebral metabolism in a neonatal swine model.

Authors:  Constantine D Mavroudis; Tiffany Ko; Lindsay E Volk; Benjamin Smood; Ryan W Morgan; Jennifer M Lynch; Mahima Davarajan; Timothy W Boorady; Daniel J Licht; J William Gaynor; Christopher E Mascio; Todd J Kilbaugh
Journal:  J Thorac Cardiovasc Surg       Date:  2020-12-11       Impact factor: 5.209

4.  Association Between Hyperoxemia and Increased Cell-Free Plasma Hemoglobin During Cardiopulmonary Bypass in Infants and Children.

Authors:  Catherine Gretchen; Hϋlya Bayir; Patrick M Kochanek; Kristine Ruppert; Melita Viegas; David Palmer; Nahmah Kim-Campbell
Journal:  Pediatr Crit Care Med       Date:  2022-02-01       Impact factor: 3.624

Review 5.  Normothermia for pediatric and congenital heart surgery: an expanded horizon.

Authors:  Ahmad Mahir Shamsuddin; Ahmad Mohd Nikman; Saedah Ali; Mohd Rizal Mohd Zain; Abdul Rahim Wong; Antonio Francesco Corno
Journal:  Front Pediatr       Date:  2015-04-28       Impact factor: 3.418

6.  Variation of perioperative plasma mitochondrial DNA correlate with peak inflammatory cytokines caused by cardiac surgery with cardiopulmonary bypass.

Authors:  Chaoyi Qin; Ruiqi Liu; Jun Gu; Yajiao Li; Hong Qian; Yingkang Shi; Wei Meng
Journal:  J Cardiothorac Surg       Date:  2015-06-24       Impact factor: 1.637

7.  Normoxic and hyperoxic cardiopulmonary bypass in congenital heart disease.

Authors:  Amir Mokhtari; Martin Lewis
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

8.  Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia.

Authors:  Heba Kamal Morsi; Manar Mohammad Ismail; Hassan Abdelaziz Hassan Gaber; Amani Abdelhamid Elbasmy
Journal:  Mediators Inflamm       Date:  2016-05-19       Impact factor: 4.711

Review 9.  Oxidative Stress after Surgery on the Immature Heart.

Authors:  Daniel Fudulu; Gianni Angelini
Journal:  Oxid Med Cell Longev       Date:  2016-03-31       Impact factor: 6.543

10.  Rationale for Implementation of Warm Cardiac Surgery in Pediatrics.

Authors:  Yves Durandy
Journal:  Front Pediatr       Date:  2016-05-06       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.